About AcuFocus
AcuFocus is a company based in Irvine (United States) founded in 2001 was acquired by Bausch & Lomb in January 2023. AcuFocus has raised $219.07 million across 14 funding rounds from investors including Medtronic, Bausch & Lomb and KKR. The company has 27 employees. AcuFocus offers products and services including Stellaris Elite, enVista, Bi-Blade, TENEO, and Cohen-Benner Contact Lens. AcuFocus operates in a competitive market with competitors including Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
- Headquarter Irvine, United States
- Employees 27
- SectorsHealthcare
- Website acufocus.com
- Social LinkedIn X Facebook
- Acquired by Bausch & Lomb (Jan 2023)
- Legal Name Acufocus, Inc.
- Total Equity Funding$219.07M (USD)
in 14 rounds
- InvestorsMedtronic
& 10 more
- Employee Count27
- Acquired byBausch & Lomb
(Jan 2023)
Products & Services of AcuFocus
AcuFocus offers a comprehensive portfolio of products and services, including Stellaris Elite, enVista, Bi-Blade, TENEO, and Cohen-Benner Contact Lens.
Vision enhancement system for dual-function surgical platforms.
Lens for vision correction in cataract procedures.
Tool for precise retinal surgery and tissue removal.
Laser system for refractive eye surgery applications.
Lens for posterior visualization during eye operations.
Funding Insights of AcuFocus
AcuFocus has successfully raised a total of $219.07M across 14 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $219.07M
- Total Rounds 14
- First Round $9M
(Nov 2002)
- Investors Count 11
Latest 10 of 14 funding rounds of AcuFocus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | – | Series H | – | Flying L Partners | – |
| Aug 2018 | $23.97M | Series F | – | – | – |
| Oct 2016 | $74.92M | Series F | – | KKR | – |
| Aug 2016 | $2M | Debt – Conventional | – | – | – |
| Jun 2016 | $1.87M | Debt – Conventional | – | – | – |
| May 2016 | $5.8M | Debt – Conventional | – | – | – |
| Nov 2015 | $1.99M | Debt – Conventional | – | – | – |
| Sep 2014 | $21M | Series F | – | Versant Ventures, Accuitive Medical Ventures | – |
| Nov 2011 | $65M | Series E | – | HealthCare Royalty Partners | |
| Jun 2009 | $6M | Series D | – | – | – |
11 investors in total: 11 institutional.
Investors in AcuFocus
AcuFocus has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Bausch & Lomb and KKR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Flying L Partners is focused on ophthalmic sector investments. | – | flyinglpartners.com | - | |
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States | |
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | – | versantventures.com | - | |
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | – | amvpartners.com | Duluth, United States | |
Healthcare royalty investments are focused on US and UK markets. | – | healthcareroyalty.com | Stamford, United States | |
Private equity investments are directed toward multiple sectors. | 1986 | carlyle.com | - | |
Venture capital fund focused on early-stage healthcare startups | – | svhealthinvestors.com | Boston, United States | |
Life science & tech focused VC firm investing in companies in the US | – | threearchpartners.com | San Mateo, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | bausch.com | Bridgewater, United States |
Investor details for AcuFocus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AcuFocus
34 people are tracked at AcuFocus (12 in leadership, 12 in board & advisors, 10 in team); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Alan Waterhouse | CEO | Leadership |
Magda Michna | Chief Global Clinical, Medical & Regulatory Affairs Officer | Leadership |
Jason Safabash | VP of Research & Development | Leadership |
Gloria D. Sefton | Chief Legal Officer | Leadership |
David Holland | Director | Leadership |
Yari L. Mitchell | Chief Business Development Officer | Leadership |
Sandra Selvaggi | Chief Operations Officer & Head of Manufacturing & Quality Operations | Leadership |
Christina Wardell | Director of Commercial Operations & IT | Leadership |
John Garland | Global Vice President of Sales | Leadership |
Greg Scandone | East Coast Sales Director | Leadership |
Laura Schall | Director, Clinical Operations | Leadership |
Sandra Bozich DeSelle, OD, FAAO | Director, Medical Affairs and Medical Safety | Leadership |
Gerd U. Auffarth | Physician Advisor | Board & advisors |
Robert Edward T. Ang | Physician Advisor | Board & advisors |
Jacqueline Beltz | Physician Advisor | Board & advisors |
Burkhard Dick | Physician Advisor | Board & advisors |
Eric Donnenfeld | Physician Advisor | Board & advisors |
Richard Lindstrom | Physician Advisor | Board & advisors |
Sathish Srinivasan | Physician Advisor | Board & advisors |
Vance Thompson | Physician Advisor | Board & advisors |
14 more people are available in the full profile.
Complete people profiles for AcuFocus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AcuFocus
4 dated milestones of AcuFocus across 22 years, from founding to its latest funding, stage changes and deals.
- Founded AcuFocus is founded.
- Funding First funding round of $9.0M.
- Funding Latest funding round, Series H,.
- Exit Acquired by Bausch & Lomb.
Competitors of AcuFocus
AcuFocus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bausch.com | 1853 | Bridgewater, United States | – | 1,681 | Ophthalmic pharmaceuticals and instruments are developed for eye care. | |
| dopavision.com | 2017 | Berlin, Germany | $15.54M | – | Digital therapeutics for myopia are developed via retinal light stimulation. | |
| appasamy.com | 1978 | Chennai, India | – | 4,259 | Ophthalmic instruments and pharmaceutical products are developed for eye care. | |
| katalystsurgical.com | 2010 | St. Louis, United States | $340,000 | 53 | Titanium ophthalmic surgical instruments are manufactured and repaired. | |
| lamellar.com | 2007 | Bellshill, United Kingdom | $18.39M | 5 | Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies | |
| moria-surgical.com | 1820 | Antony, France | – | – | Precision instruments for eye surgery are designed and manufactured. | |
| svision100.com | 2017 | Jinshan, China | $21.06M | – | Provider of smart eye protection solutions for children and teenagers to prevent myopia | |
| katena.com | 1975 | Tampa, United States | $7.5M | 145 | Ophthalmic surgical instrument manufacturer | |
| dorcglobal.com | 1983 | Zuidland, Netherlands | – | – | Ophthalmic research center | |
| aurolab.com | 1992 | Madurai, India | – | 102 | Manufacturer of high quality ophthalmic consumables |
Detailed competitors of AcuFocus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acufocus
Complete news archive for AcuFocus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to AcuFocus
10 companies that operate in the same segment as AcuFocus (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AcuFocus
AcuFocus was founded in 2001 and raised its 1st funding round 1 year after it was founded.
AcuFocus is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Alan Waterhouse is the current CEO of AcuFocus.
AcuFocus is a funded company, having raised a total of $219.07M across 14 funding rounds to date. The company's 1st funding round was a Series D of $6M, raised on Nov 2002.
AcuFocus has 27 employees.
Developer of small aperture technology-based ophthalmic devices. The platform uses the pinhole effect to bring objects into focus. Two products have been developed - KAMRA corneal inlay for presbyopia and IC-8 intraocular lens for cataract. Also, has a diagnostic and surgical planning instrument AcuTarget HD.
AcuFocus's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
AcuFocus offers Stellaris Elite, enVista, Bi-Blade, TENEO, and Cohen-Benner Contact Lens.
AcuFocus has 11 investors. Key investors include Medtronic, Bausch & Lomb, KKR, The Carlyle Group, and Flying L Partners.
AcuFocus operates through Acufocus, Inc..
Yes. AcuFocus was acquired by Bausch & Lomb in January 2023.